NET ASSET VALUE – 30 April 2025

MARKN.

On the 30 April 2025 Flerie AB's Net Asset Value (NAV) was SEK 3,965 million and NAV per share was SEK 50.79.



Allocation of NAV
Share of portfolio companyFair value (MSEK)Part of NAV per share (SEK)Share of NAV
Product Development    
Prokarium42%4525.8011.4%
Xspray Pharma18%2312.965.8%
Empros Pharma79%2042.625.2%
KAHR Medical31%1822.334.6%
Lipum57%1822.334.6%
Atrogi37%1762.254.4%
Xintela61%1652.114.1%
Microbiotica10%1291.653.2%
Geneos Therapeutics12%931.192.3%
AnaCardio14%690.891.7%
Mendus24%600.771.5%
Toleranzia53%600.771.5%
EpiEndo Pharmaceuticals9%540.701.4%
Synerkine Pharma43%540.701.4%
Vitara Biomedical11%480.621.2%
Buzzard Pharmaceuticals14%320.400.8%
Sixera Pharma24%270.350.7%
Egetis Therapeutics2%220.280.6%
Alder Therapeutics21%170.220.4%
Amarna Therapeutics58%110.140.3%
Strike Pharma16%90.110.2%
Total 2,27729.1757.4%





Commercial Growth    
Symcel30%1922.464.8%
NorthX Biologics92%1892.424.8%
Chromafora30%730.931.8%
Nanologica43%470.611.2%
Frontier Biosolutions2%180.230.5%
Bohus Biotech45%170.210.4%
Total 5366.8713.5%





Limited Partnerships, total 901.152.3%
     
Assets related to Portfolio companies 2663.416.7%
Other assets and liabilities 79510.1820.0%
     
Net asset value 3,96550.79100.0%
  

 
Datum 2025-05-07, kl 08:00
Källa MFN
100% cashback på aktiecourtage! Handla aktier på eToro och få tillbaka 100% av ditt courtage i 3 månader. Hur? Registrera dig här nu direkt för att ta del av erbjudandet.
Cashback är begränsad till högst $100. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.